Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Understanding Obesity Pandemic

4. Market Trends
    4.1 Increasing Prevalence of Obesity
    4.2 Heavy R&D Spending
    4.3 Strategic Alliances
    4.4 Emerging New Treatments
          4.4.1 Drug Combos
          4.4.2 Cannabinoids
          4.4.3 Information and Communication Technologies

5. Global Obesity Drug Market: Industry Performance
    5.1 Market Overview
    5.2 Major Drugs
          5.2.1 Orlistat/Xenical
          5.2.2 Meridia
          5.2.3 Acomplia
          5.2.4 Alli
    5.3 Future Obesity Drug Pipeline
          5.3.1 Liraglutide
          5.3.2 Armodafinil
          5.3.3 Sulfamethoxazole/trimethoprim
          5.3.4 IHBG-10
    5.4 Top Selling Weight-Loss Supplements

6. Regional Level Developments
    6.1 North America
          6.1.1 US
          6.1.2 Mexico
          6.1.3 Canada
    6.2 Latin America
          6.2.1 Brazil
    6.3 Europe
          6.3.1 UK
          6.3.2 France
          6.3.3 Germany
    6.4 Asia-Pacific
          6.4.1 Australia
          6.4.2 New Zealand
          6.4.3 India
          6.4.4 China
    6.5 Middle East and Africa
          6.5.1 UAE
          6.5.2 Qatar
          6.5.3 Saudi Arabia
          6.5.4 South Africa

7. Competitive Landscape
    7.1 F Hoffmann-La Roche Ltd
    7.2 Abbott Laboratories
    7.3 AstraZeneca Plc
    7.4 Sanofi-Aventis SA
    7.5 Takeda Pharmaceutical Company Limited